Skip to main content
OpenTrials

Clinical trial condition

Relapsing-Remitting Multiple Sclerosis

Explore clinical trials studying Relapsing-Remitting Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

98 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Relapsing-Remitting Multiple Sclerosis trial results

Completed

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

NCT00078338

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Barrow Neurology Clinics Phoenix, Arizona, United States
  • Northwest NeuroSpecialists Tucson, Arizona, United States
  • University of California, Davis Sacramento, California, United States
View all 80 locations
View Trial Details
Completed

Ireland Natalizumab (TYSABRI) Observational Program

NCT01943526

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research site Cork, County Cork, Ireland
  • Research site Dublin, County Dublin, Ireland
  • Research site Galway, County Galway, Ireland
  • Research site Tralee, County Kerry, Ireland
View Trial Details
Completed

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

NCT02823951

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Alabama Neurology Associates Birmingham, Alabama, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • Savannah Neurology Specialists Savannah, Georgia, United States
  • Northshore University Evanston, Illinois, United States
View all 23 locations
View Trial Details
Completed

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

NCT00288626

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Ohio State University School of Medicine Columbus, Ohio, United States
  • Baylor College of Medicine Houston, Texas, United States
  • M.D. Anderson Cancer Center; Transplant site, please contact Baylor College of Medicine Houston, Texas, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany

NCT02125604

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Augsburg, Germany
  • Research Site Bamburg, Germany
  • Research Site Bayreuth, Germany
  • Research Site Berlin, Germany
View all 19 locations
View Trial Details
Completed

BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis

NCT01156311

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Danbury, Connecticut, United States
  • Research Site Atlanta, Georgia, United States
View all 16 locations
View Trial Details

Related conditions